Mesoblast Stock Quote MESO - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

14.55

Bid

8.45

Ask

23.00

Volume

1,930,187

13.70 Day's Range 15.67

0.00 52 Week Range 0.00

Market Cap

1.661B

Previous Close

16.76

Open

14.96

Last Trade

14.89

Last Trade Time

Financial Volume

$ 27,953,846

VWAP

14.4825

Average Volume (3m)

Shares Outstanding

114,178,411

Dividend Yield

PE Ratio

-3.12

Earnings Per Share (EPS)

-0.77

Revenue

9.25M

Net Profit

-87.96M

Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-... Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.mesoblast.com

Headquarters

Melbourne, Victoria, Aus

Founded

Mesoblast Limited is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MESO. The last closing price for Mesoblast was $16.76. Over the last year, Mesoblast shares have traded in a share price range of $ 0.00 to $ 0.00.

Mesoblast currently has 114,178,411 shares outstanding. The market capitalization of Mesoblast is $1.91 billion. Mesoblast has a price to earnings ratio (PE ratio) of -3.12.

Overall Flow

Bullish

Net Premium

389k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

25.00%

Sweeps Ratio

0.00%

Mesoblast’s RYONCIL® is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) Therapy

RYONCIL (remestemcel-L) is the first MSC product approved by FDA for any indication.RYONCIL is the first FDA-approved therapy for children aged 2 months and older, including adolescents and...

Mesoblast to be Added to Nasdaq Biotechnology Index

NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced its upcoming...

Form F-3 - Registration statement by foreign private issuers

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

FDA Grants Revascor® (Rexlemestrocel-L) Regenerative Medicine Advanced Therapy (RMAT) Designation in Children with Congenital Heart Disease

NEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced the United States...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

MESO - Frequently Asked Questions (FAQ)

What is the current Mesoblast share price?

The current share price of Mesoblast is $ 14.55

How many Mesoblast shares are in issue?

Mesoblast has 114,178,411 shares in issue

What is the market cap of Mesoblast?

The market capitalisation of Mesoblast is USD 1.91B

What is the 1 year trading range for Mesoblast share price?

Mesoblast has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of Mesoblast?

The price to earnings ratio of Mesoblast is -3.12

What is the cash to sales ratio of Mesoblast?

The cash to sales ratio of Mesoblast is 29.63

What is the reporting currency for Mesoblast?

Mesoblast reports financial results in USD

What is the latest annual turnover for Mesoblast?

The latest annual turnover of Mesoblast is USD 9.25M

What is the latest annual profit for Mesoblast?

The latest annual profit of Mesoblast is USD -87.96M

What is the registered address of Mesoblast?

The registered address for Mesoblast is LEVEL 38, 55 COLLINS STREET, MELBOURNE, VICTORIA, 3000

What is the Mesoblast website address?

The website address for Mesoblast is www.mesoblast.com

Which industry sector does Mesoblast operate in?

Mesoblast operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MYSZMy Size Inc	$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	$ 0.24 (65.06%)	354.32M
APTOAptose Biosciences Inc	$ 0.28 (64.51%)	305.1M
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.606999 (6.49%)	292.16M
NVDANVIDIA Corporation	$ 134.70 (3.08%)	287.21M
PLTRPalantir Technologies Inc	$ 80.55 (8.54%)	277.63M